title: Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis.
authors.forename: T D
authors.initials: TD
authors.lastname: Polk
authors.forename: S R
authors.initials: SR
authors.lastname: Russell
authors.forename: K M
authors.initials: KM
authors.lastname: Gehrs
authors.forename: J C
authors.initials: JC
authors.lastname: Folk
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004343:Drug Implants; D015774:Ganciclovir / Q000008:administration & dosage*; D006801:Humans
chemical_list: D000998:Antiviral Agents; D003692:Delayed-Action Preparations; D004343:Drug Implants; D015774:Ganciclovir